{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:19:09Z","timestamp":1791922749017,"version":"4.3.4"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ando.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:04:19Z","timestamp":1537833859000},"page":"240-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Graves\u2019 disease, multinodular goiter and subclinical hyperthyroidism"],"prefix":"10.1016","volume":"80","author":[{"given":"Pierre","family":"Bel Lassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aglaia","family":"Kyrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lytrivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Corvilain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2018.09.004_bib0420","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ando.2018.09.004_bib0425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000438909","article-title":"Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress?","volume":"4","author":"Wiersinga","year":"2015","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2018.09.004_bib0430","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000438750","article-title":"The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism","volume":"4","author":"Biondi","year":"2015","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2018.09.004_bib0435","doi-asserted-by":"crossref","first-page":"R325","DOI":"10.1530\/EJE-16-0276","article-title":"Management of endocrine disease: subclinical thyrotoxicosis: prevalence, causes and choice of therapy","volume":"176","author":"Carl\u00e9","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.09.004_bib0440","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease","volume":"87","author":"Andersen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0445","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/M15-0640","article-title":"Screening and treating subclinical thyroid disease: getting past the impasse","volume":"162","author":"Cappola","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0450","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/M15-0483","article-title":"Screening for thyroid dysfunction: U.S Preventive Services Task Force recommendation statement","volume":"162","author":"LeFevre","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0455","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1210\/jc.2008-1696","article-title":"High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over","volume":"94","author":"Somwaru","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0460","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/jc.2009-1845","article-title":"Age- and race-based serum thyrotropin reference limits","volume":"95","author":"Surks","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0465","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2265.1993.tb01006.x","article-title":"Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations","volume":"38","author":"Konno","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0470","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF03346431","article-title":"Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Troms\u00f8 study","volume":"31","author":"Bj\u00f8rndal","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2018.09.004_bib0475","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2265.2009.03696.x","article-title":"Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU\/L: a prospective study","volume":"72","author":"Rosario","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0480","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jcem.83.3.4624","article-title":"Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark","volume":"83","author":"Laurberg","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2009.08.013","article-title":"Iodine intake as a determinant of thyroid disorders in populations","volume":"24","author":"Laurberg","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0490","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s40618-016-0516-7","article-title":"The phenotype of newly diagnosed Graves\u2019 disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study","volume":"39","author":"Bartalena","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2018.09.004_bib0495","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0016","article-title":"Management of simple nodular goiter: current status and future perspectives","volume":"24","author":"Heged\u00fcs","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2018.09.004_bib0500","first-page":"499","article-title":"Ultrasonic assessment of thyroid nodules, and iodine status of French adults participating in the SU.VI.MAX study","volume":"62","author":"Valeix","year":"2001","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2018.09.004_bib0505","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2265.2001.01365.x-i2","article-title":"Somatic and germline mutations of the TSH receptor and thyroid diseases","volume":"55","author":"Corvilain","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-13-1003","article-title":"TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients","volume":"170","author":"Chami","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.09.004_bib0515","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.2010.03908.x","article-title":"Subclinical thyrotoxicosis in an outpatient population \u2013 predictors of outcome","volume":"74","author":"Schouten","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0105","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2010-0854","article-title":"The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism","volume":"96","author":"Vadiveloo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0520","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/105072501300176453","article-title":"Iodine excess and hyperthyroidism","volume":"11","author":"Roti","year":"2011","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.09.004_bib0525","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","article-title":"Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom","volume":"34","author":"Parle","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0530","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.167.14.1533","article-title":"Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians","volume":"167","author":"Meyerovitch","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0535","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ando.2018.09.004_bib0540","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/thy.2012.0471","article-title":"Thyroid hormone levels within reference range are associated with heart rate, cardiac structure, and function in middle-aged men and women","volume":"23","author":"Roef","year":"2013","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.09.004_bib0545","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/eurheartj\/ehx050","article-title":"Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update","volume":"39","author":"Floriani","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ando.2018.09.004_bib0550","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/jc.2002-021046","article-title":"The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities","volume":"88","author":"Sgarbi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0555","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients","volume":"85","author":"Biondi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0560","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/thy.2010.0333","article-title":"The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias","volume":"22","author":"Kaminski","year":"2012","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.09.004_bib0565","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2265.2010.03882.x","article-title":"Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up","volume":"73","author":"D\u00f6rr","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0570","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.2009.0272","article-title":"Thyroid function and left ventricular structure and function in the Framingham Heart Study","volume":"20","author":"Pearce","year":"2010","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.09.004_bib0575","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2011-1978","article-title":"Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk","volume":"97","author":"Nanchen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0580","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2018.09.004_bib0585","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0590","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hyperthyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ando.2018.09.004_bib0595","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archinte.167.9.928","article-title":"Association between serum free thyroxine concentration and atrial fibrillation","volume":"167","author":"Gammage","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0600","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2018.09.004_bib0605","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2018.09.004_bib0610","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ando.2018.09.004_bib0615","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/EJE-09-0845","article-title":"Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study","volume":"162","author":"Sgarbi","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.09.004_bib0620","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1210\/jc.2013-4184","article-title":"Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study","volume":"99","author":"Selmer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0625","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0630","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8529(18)30338-4","article-title":"Effects of thyroid hormones on bone and mineral metabolism","volume":"19","author":"Mosekilde","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ando.2018.09.004_bib0635","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.1993.tb02403.x","article-title":"Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?","volume":"39","author":"F\u00f6ldes","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0640","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/thy.1999.9.539","article-title":"Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women","volume":"9","author":"G\u00fcrlek","year":"1999","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"8","key":"10.1016\/j.ando.2018.09.004_bib0645","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1210\/jc.2014-1051","article-title":"Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study","volume":"99","author":"Garin","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0650","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00774-017-0828-5","article-title":"The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies","volume":"36","author":"Yang","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0655","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","article-title":"Risk for fracture in women with low serum levels of thyroid-stimulating hormone","volume":"134","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0660","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1001\/archinternmed.2010.424","article-title":"Subclinical thyroid dysfunction and incident hip fracture in older adults","volume":"170","author":"Lee","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0665","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2015.5161","article-title":"Subclinical thyroid dysfunction and fracture risk: a meta-analysis","volume":"313","author":"Blum","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2018.09.004_bib0670","first-page":"4269","article-title":"Body weight and body composition changes after treatment of hyperthyroidism","volume":"83","author":"L\u00f6nn","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0675","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/jcem-55-3-459","article-title":"Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment","volume":"55","author":"Muls","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0680","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cen.13237","article-title":"Total thyroidectomy: a clue to understanding the metabolic changes induced by subclinical hyperthyroidism?","volume":"86","author":"Bel Lassen","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0685","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1210\/jc.2004-2225","article-title":"Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population","volume":"90","author":"Knudsen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0690","first-page":"1206","article-title":"The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects","volume":"86","author":"Bakker","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0695","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1210\/jc.2012-2284","article-title":"Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people","volume":"97","author":"Gan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0700","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/cen.13458","article-title":"The association between subclinical thyroid dysfunction and dementia: The Health Aging and Body Composition (Health ABC) Study","volume":"87","author":"Aubert","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0705","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2016-2129","article-title":"Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies","volume":"101","author":"Rieben","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0710","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/BF03348807","article-title":"Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves\u2019 disease","volume":"15","author":"van Soestbergen","year":"1992","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.ando.2018.09.004_bib0715","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.0.1340337","article-title":"Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study","volume":"134","author":"Nolte null","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2018.09.004_bib0720","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00330-004-2238-z","article-title":"Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Effect of iodinated contrast media on thyroid function in adults","volume":"14","author":"van der Molen","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ando.2018.09.004_bib0725","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-08-0779","article-title":"Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy","volume":"160","author":"Fast","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.09.004_bib0730","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2002-021554","article-title":"Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter","volume":"88","author":"Nieuwlaat","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0735","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2265.2003.01918.x","article-title":"Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres","volume":"60","author":"Silva","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0740","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/jc.2004-0458","article-title":"Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine","volume":"90","author":"Albino","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0745","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/thy.2010.0088","article-title":"Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake","volume":"21","author":"Ceccarelli","year":"2011","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.ando.2018.09.004_bib0750","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/jc.2011-3335","article-title":"Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter","volume":"97","author":"Fast","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0755","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1210\/jc.2015-1026","article-title":"Thiamazole pretreatment lowers the (131)I activity needed to cure hyperthyroidism in patients with nodular Goiter","volume":"100","author":"Kyrilli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0760","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000478927","article-title":"European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS","volume":"6","author":"Russ","year":"2017","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2018.09.004_bib0765","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00268-008-9579-8","article-title":"Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review","volume":"32","author":"Agarwal","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2018.09.004_bib0770","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00268-008-9477-0","article-title":"Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature","volume":"32","author":"Moalem","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2018.09.004_bib0775","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2018.09.004_bib0780","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/msy.2003.61","article-title":"The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients","volume":"133","author":"Thomusch","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2018.09.004_bib0785","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/cen.13088","article-title":"Thyroid lobectomy is an effective option for unilateral benign nodular disease","volume":"85","author":"Lytrivi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0790","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jc.2012-1063","article-title":"Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies","volume":"97","author":"Verloop","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.09.004_bib0795","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EC-14-0137","article-title":"Treatment of subclinical hyperthyroidism: effect on left ventricular mass and function of the heart using magnetic resonance imaging technique","volume":"4","author":"Mark","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2018.09.004_bib0800","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2265.1998.00427.x","article-title":"Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women","volume":"48","author":"Faber","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0805","first-page":"973","article-title":"Changes in body composition in women following treatment of overt and subclinical hyperthyroidism","volume":"14","author":"Greenlund","year":"2008","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2018.09.004_bib0810","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2265.2006.02660.x","article-title":"Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial","volume":"65","author":"Heemstra","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.09.004_bib0815","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejim.2011.03.008","article-title":"Should we treat mild subclinical\/mild hyperthyroidism?","volume":"22","author":"Wiersinga","year":"2011","journal-title":"Yes. Eur J Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0820","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejim.2011.03.009","article-title":"Should we treat mild subclinical\/mild hyperthyroidism?","volume":"22","author":"Vanderpump","year":"2011","journal-title":"No. Eur J Intern Med"},{"key":"10.1016\/j.ando.2018.09.004_bib0825","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid Off J Am Thyroid Assoc"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618312472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618312472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:51:40Z","timestamp":1757717500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426618312472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0003426618312472"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2018.09.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graves\u2019 disease, multinodular goiter and subclinical hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}